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Objectives The purpose of this study was to determine the role of circulating endothelial progenitor cells with osteoblastic
phenotype (EPC-OCN) in human aortic valve calcification (AVC).
Background Recent evidence suggests that rather than passive mineralization, AVC is an active atherosclerotic process with
an osteoblastic component resembling coronary calcification. We have recently identified circulating EPCs with
osteogenic properties carrying both endothelial progenitor (CD34, KDR) and osteoblastic (osteocalcin [OCN]) cell
surface markers.
Methods Blood samples from controls (n  22) and patients with mild to moderate calcific aortic stenosis (mi-moAS, n  17),
severe calcific AS (sAS, n  26), and both sAS and severe coronary artery disease (sCAD) (n  33) were collected
during diagnostic coronary angiography. By using flow cytometry, peripheral blood mononuclear cells were analyzed
for CD34, KDR, and OCN. Resected normal and calcified aortic valves were analyzed histologically.
Results Patients with mi-moAS and patients with sAS/sCAD had significantly less EPCs (CD34/KDR/OCN) than controls.
Patients with sAS showed significantly higher numbers of EPC-OCN (CD34/KDR/OCN) than controls. In addition,
the percentage of EPC costaining for OCN was higher in all disease groups compared with controls. A subgroup analy-
sis of younger patients with bicuspid sAS showed a similar pattern of significantly lower EPCs but a high percentage
of coexpression of OCN. Immunofluorescence showed colocalization of nuclear factor kappa-B and OCN in diseased
and normal valves. CD34/OCN cells were abundant in the endothelial and deeper cell layers of calcific aortic
valve tissue but not in normal aortic valve tissue.
Conclusions Circulating EPC-OCN may play a significant role in the pathogenesis and as markers of prognostication of calcific
AS. (J Am Coll Cardiol 2012;60:1945–53) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.042Calcific aortic stenosis (AS) is a common valve disease
affecting up to 26% of adults older than 65 years of age (1),
with 3% to 5% showing moderate to severe disease (2),
making it the most common indication for valve replace-
ment in the United States (3). In contrast to previous
paradigms depicting aortic valve calcification (AVC) as a
passive degenerative mineralization process (4), recent evi-
dence suggests that AVC is an active process closely related
to coronary artery atherosclerosis and calcification (5). In
addition to features of inflammation and increased oxidative
stress (6,7), animal models have demonstrated that AVC is
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accepted July 10, 2012.characterized by an osteoblastic component (8,9). Indeed,
we have recently shown that patients with early and severe
coronary atherosclerosis have high levels of circulating
endothelial progenitor cells with osteoblastic (osteocalcin
[OCN]) phenotype (EPC-OCN) (10). Moreover, we have
found that these EPC-OCN are retained within the coronary
circulation of patients with endothelial dysfunction (11).
See page 1954
The current study was designed to test the hypothesis
that patients with varying degrees of calcific aortic stenosis
(AS) show high numbers of circulating EPC-OCN, and
furthermore that these cells are present in the aortic valve
tissue. By comparing patients with varying degrees of
calcific AS and coronary artery disease (CAD) with con-
trols, we sought to establish differences in distribution
patterns of circulating endothelial progenitor cells (EPCs)
(defined in this study as CD34/KDR/OCN) and
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KDR/OCN). In addition, by
using histological techniques, we
sought to investigate whether
EPC-OCN can be detected in
resected valve tissue of patients
undergoing aortic valve replace-
ment for symptomatic severe cal-
cific aortic stenosis (sAS).
Methods
The study was approved by the
institutional review board of the
Mayo Foundation, and all study
subjects provided written, in-
formed consent. A total of 59
consecutive patients with clinical
and echocardiographic sAS were
referred for preoperative coro-
nary angiography. A total of 26
of these 59 patients were found
to have sAS but normal coronary
arteries; the remaining 33 pa-
tients were found to have both
sAS and severe coronary artery
disease (sCAD). The severity of
AS was determined using standard echocardiographic
methods (defined as a mean aortic valve gradient of 40
mm Hg and an aortic valve area of 0.9 cm2). In addition,
we analyzed blood samples from 17 patients undergoing
diagnostic angiography for assessment of CAD with only
mild to moderate AS. A total of 22 patients with normal
coronary angiograms and echocardiographically normal aor-
tic valves served as the control group. Patients with acute
coronary syndromes (unstable angina or acute myocardial
infarction), heart failure (ejection fraction 50%), or severe
renal or liver disease were excluded. None of the subjects
had a clinical diagnosis of Paget’s disease, a bone fracture
within the past 5 years, or end-stage renal disease.
Flow cytometry. Peripheral blood mononuclear cells were
isolated from fresh blood samples (collected in ethylenedi-
aminetetraacetic acid tubes) using a Ficoll density gradient,
and immunofluorescent cell staining was performed using
the following fluorescent conjugated antibodies: CD34-
PerCP Cy 5.5 (Becton Dickinson, Franklin Lakes, New
Jersey), kinase insert domain receptor allophycocyanin (vas-
cular endothelial growth factor receptor 2, R&D Systems,
Minneapolis, Minnesota), and the appropriate isotype con-
trols as previously described (10,11). In addition, osteocalcin
(OCN) cells were identified using an anti-human OCN
antibody (Santa Cruz Biotechnology, Santa Cruz, Califor-
nia) with a fluorescein isothiocyanate secondary antibody
(Jackson ImmunoResearch, West Grove, Pennsylvania)
(10). Live cells were detected using propidium iodide
Abbreviations
and Acronyms
AS  aortic stenosis
AVC  aortic valve
calcification
CAD  coronary artery
disease
EPC  endothelial
progenitor cell
EPC-OCN  endothelial
progenitor cells with
osteoblastic phenotype
mi-moAS  mild to
moderate calcific aortic
stenosis
NFkB  nuclear factor
kappa-B
OCN  osteocalcin
PBS  phosphate-buffered
saline
sAS  severe calcific
aortic stenosis
sCAD  severe coronary
artery disease
VIC  valve interstitial cellexclusion (Becton Dickinson). Cell fluorescence was mea- asured immediately after staining (Becton Dickinson, FACS
Calibur), and data were analyzed using CellQuest software
(Becton Dickinson). A total of 150,000 events were
counted, and final data were obtained within the lympho-
cyte gate (determined using light scatter [forward and side
scatter]). Representative examples of data plots have been
published (10). The investigator performing the cell analysis
was unaware of the results of the patient classification.
Immunofluorescence. Severely calcified aortic valves were
resected at the time of clinically indicated aortic valve
replacement for severe AS. Normal aortic valve specimens
were acquired during autopsies.
To confirm the correlation of CD34 with OCN and
nuclear factor kappa-B (NFkB) with OCN, double-staining
immunofluorescence was performed in frozen cross sections
(nondecalcified tissue). Polyclonal (OCN, 1:100, Santa
Cruz Biotechnology) and monoclonal (NFkB, 1:50, Cell
Signaling Technology Inc., Danvers, Massachusetts; CD34,
1:500, Invitrogen, Grand Island, New York) primary anti-
bodies were used. The secondary antibodies were used
according to the vendor’s instruction.
Frozen sections were fixed in ice-cold methanol for 15
min and washed 3 times in phosphate-buffered saline (PBS)
for 5 minutes. Antigen retrieval was done by steaming the
tissue for 25 min followed by 5 min PBS washing. Endog-
enous peroxidase activity was blocked by a 50/50 solution of
methanol and 3% H2O2 followed by 5 min of PBS washing.
he sections were blocked in 5% bovine serum albumin in
BS for 25 min and the first antibody diluted in blocking
uffer was added overnight. Sections were then washed 3
imes with PBS for 5 min and the secondary antibody was
dded in diluted blocking buffer for 30 min at room
emperature. Sections were finally washed 3 times with PBS
or 5 min and then mounted with DAPI.
Images were acquired by using a computer-aided image-
nalysis program (AxioCam digital camera, AxioObserver. Z1
nd AxioVision software v4.7.2.0, Carl Zeiss MicroImaging,
nc., Thornwood, New York). Under Apo Tome mode,
ictures were first taken separately for each individual color
hannel (red for CD34 or NFkB, green for OCN, and blue
or DAPI) at the same area of the tissue for part inspection,
nd then an additional multichannel merged image was
utomatically generated through which the correlations
etween the positive stainings and the stainings with nu-
leus are presented.
tatistics. We used the Shapiro-Wilk test to determine
ormal distribution. Data that are not normally distributed
re presented as median (interquartile [25th to 75th per-
entile] range). Normally distributed data are shown as
ean  SD. Continuous variables were tested using 1-way
nalysis of variance. Dichotomous variables were compared
sing the Fisher exact test. Analysis of variance was used to
est for group differences in EPC results. Skewed data were
ransformed using a log-transformation. Pairwise compari-
ons of the 3 diseased groups with the normal group were
djusted using Dunnett’s method. Analysis of covariance
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tions changed when adjusting for cardiovascular risk factors.
A p value0.05 was considered statistically significant. The
Statistical Package for the Social Sciences version 18.0
(SPSS Inc., Chicago, Illinois) and SAS version 9.2 (SAS
Institute Inc., Cary, North Carolina) were used to conduct
analyses.
Results
Patient demographics. Patient characteristics are summa-
rized in Table 1. Patients with normal endothelial function
nd normal aortic valves were younger, less likely to be male,
nd less likely to present with history of hypertension and
iabetes mellitus than patients in the disease groups.
irculating osteoblastic progenitor cells. Patients with
sAS and normal coronary arteries showed significantly
higher numbers of circulating EPC-OCN than controls
(Fig. 1). The percentage of EPCs costaining for OCN was
higher in all disease groups compared with controls, reach-
ing statistical significance in all but the sAS group (Fig. 2).
Circulating EPCs. Patients with mild to moderate calcific
aortic stenosis (mi-moAS) and those with both sAS and
sCAD showed significantly fewer circulating EPCs
(CD34/KDR/OCN) than controls (Fig. 3).
Analysis of covariance after adjustment for confounding
risk factors. Analysis of covariance showed that after ad-
justment for diabetes, hypertension, and smoking, the
statistically significant differences held except for the com-
Patient Demographics and Clinical DataTable 1 Patient Demographics and Clinical
Control
(n  22)
Mi-M
(n 
Age (yrs) 47 9 68
Male (%) 27 7
RRsyst BP (mm Hg) 130 20 126
RRdiast 74 10 68
Total cholesterol (mg/dl) 181 32 165
LDL (mg/dl) 106 28 89
HDL (mg/dl) 53 11 44
eGFR (MDRD) 81 12 71
hsCRP* 2.52 1.9
BMI (kg/m2) 296 30
AV area/TVI (cm2) — 1.7
Mean AV gradient (mm Hg) — 19
Ejection fraction (%) — 54
HTN (%) 36 8
HLP 59 6
DM 0 1
FH (%) 73 2
Smoking† 32 4
Values are mean SD, %, or n. p values are overall tests for a differenc
standard deviation. *High-sensitivity C-reactive protein data available in n
AV  aortic valve; BMI  body mass index; BP  blood pressu
(Modification of Diet in Renal Disease [MDRD] method); FH  famil
high-sensitivity C-reactive protein; HTN  hypertension; LDL  low-
RRsyst/diast  systolic and diastolic blood pressure; sAS  severe calcific a
velocity index.parison between normal subjects and subjects with sAS/
sCAD for percent OCN of CD34/KDR cells (Table 2).
Subgroup analysis: Severe calcific bicuspid aortic valve
stenosis. To address the effect of age on the number of
EPCs and EPC-OCN, we compared 12 patients with
severe calcific bicuspid aortic valve stenosis with 12 controls
of similar age (53  2 years vs. 59  9 years, p  NS). In
his subset of study subjects, there was a significantly higher
ercentage of OCN costaining of EPCs 32  33%) versus
ontrols (8  12%, p  0.026). The numbers of circulating
EPCs (CD34/KDR/OCN) were significantly lower in
he calcific bicuspid AS group compared with controls (median
interquartile range]: 9 [27] vs. 27 [55], p  0.028). Patients
ith early sAS due to bicuspid aortic valve disease showed
igher numbers of circulating EPC-OCN than controls,
ithout reaching statistical significance (CD34/KDR/
CN; median [interquartile range]: 5 [6] vs. 1 [6], p 
0.101).
Immunofluorescence. INFLAMMATION AND OSTEOBLAS-
IC ACTIVITY. Immunofluorescence staining showed colo-
calization of the marker of inflammation NFkB and osteoblas-
tic activity (OCN) in severely calcified valves (endothelial and
deeper valve tissue layers) (Figs. 4C and 4D). Of note,
NFkB/OCN colocalization also was found in noncalcified
valves, but only in the deeper valve tissue layers (Figs. 4A
and 4B).
IDENTIFICATION OF CD34/OCN CELLS. Immuno-
uorescence staining showed an abundance of CD34/
sAS
(n  26)
sAS/sCAD
(n  33) p Value
66 11 73 10 0.000
73 88 0.000
122 25 129 21 0.600
66 10 63 11 0.004
162 38 165 36 0.262
88 27 94 28 0.103
53 18 43 10 0.015
72 16 66 19 0.017
1.9 1.3 3.7 5.2 0.583
28 5 30 5 0.275
0.96 0.29 0.87 0.16 0.000
56 15 48 11 0.000
64 12 59 12 0.043
54 79 0.002
69 88 0.088
8 33 0.004
35 39 0.017
38 52 0.523
een any 2 groups analysis of variance. Data are presented as mean
4, 8, and 10 patients, respectively. †Includes ex-smokers.
 diabetes mellitus; eGFR  estimated glomerular filtration rate
y; HDL  high-density lipoprotein; HLP  hyperlipidemia; hsCRP 
lipoprotein; mi-moAS  mild to moderate calcific aortic stenosis;Data
oAS
17)
 11
6
 23
 12
 36
 23
 16
 19
 1.8
 5
 0.4
 9
 14
2
5
8
9
1
e betw
 22,
re; DM
y histor
densityortic stenosis; sCAD  severe coronary artery disease; TVI  tissue
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cell layers of resected calcific aortic valve specimen but not in
normal valves (Fig. 5).
Discussion
The present study shows for the first time that patients with
varying degrees of calcific aortic valve disease have a high
fraction of circulating EPC-OCN (CD34/KDR/OCN)
with osteogenic activity. The current study supports a potential
role of osteogenic EPCs as biomarkers for prognostication of
disease progression and in the mechanism of AVC. However,
the absolute numbers of EPCs and EPC-OCN show inter-
esting variations between the disease subgroups.
Patients with both sAS and sCAD have significantly
reduced numbers of circulating EPCs (CD34/KDR/
OCN) compared with controls, but a high percentage of
these circulating EPCs are EPC-OCN. Of note, patients
with only mi-moAS and normal coronaries have an EPC/
EPC-OCN profile similar to that of patients with both
sAS/sCAD.
In contrast, patients with sAS and normal coronaries
show normal EPCs and high EPC-OCN numbers with a
high percentage of EPC costaining for OCN. One could
hypothesize that patients with sAS but normal coronaries
may represent a subgroup of patients whose bone marrow is
capable of a surge of EPC release in response to injury,
leading to a more favorable EPC/EPC-OCN profile. In
Figure 1 Circulating EPC-OCN in All 4 Study Groups
Patients with mi-moAS and sAS showed higher numbers of circulating endothel
whereas patients with both sAS and sCAD had numbers of circulating EPC-OCN
values and interquartile ranges are shown; diamonds represent mean values. C
sis; sAS  severe calcific aortic stenosis; sCAD  severe coronary artery disecontrast, patients with both sAS and sCAD may not becapable of such a surge and, thus, show progression of
calcific atherosclerosis in multiple vascular territories be-
cause of an unfavorable imbalance between injury and repair
(i.e., low EPC numbers with a high percent of EPC-OCN).
Thus, patients with mi-moAS are an interesting group in
our current analysis, the majority of whom have what seems
to be an unfavorable EPC profile (i.e., low EPC numbers
but high EPC-OCN percentages). Because predicting the
progression of calcific AS remains difficult and medical
intervention trials have been disappointing, long-term
follow-up data of this mi-moAS group may provide insights
into the role of EPC-OCN for prognostication of disease
progression and suitability for decision-making on aggres-
sive medical management.
Data are limited on the potential role of circulating EPCs
and osteogenic precursors in calcific aortic valve disease.
Matsumoto et al. (12) compared circulating EPC numbers
and function in peripheral blood samples from 15 patients
with sAS (CAD was excluded) with 18 age-matched
controls (sAS and CAD excluded). In addition, they ana-
lyzed harvested aortic valve tissue from patients with sAS
for endothelial cell senescence. The authors found that
endothelial cells located on the aortic side of valves from
patients with sAS showed early senescence. Moreover,
circulating EPCs in patients with sAS were reduced and
showed functional impairment as assessed by a migration
assay. The authors attributed the observed changes to
genitor cells with osteoblastic phenotype (EPC-OCN) than normal subjects,
ar to those of normal subjects. *p  0.024 versus normal subjects. Median
coronary artery disease; mi-moAS  mild to moderate calcific aortic steno-ial pro
simil
AD 
ase.“biological aging.”
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current study patients with sAS and no CAD showed
numbers of circulating EPCs similar to those of controls.
This discrepancy can be explained by the fact that the
Figure 2 Percentage of OCN Costaining of EPCs in All 4 Study
All disease groups showed a higher percentage of costaining of circulating EPCs fo
the sAS group. *p  0.001, #p  0.043 versus normal subjects. Median values
in Figure 1.
Figure 3 Circulating EPCs in All 4 Study Groups
Patients with mi-moAS and patients with both sAS and sCAD showed significantly
#p  0.003 versus normal subjects. Median values and interquartile ranges are scontrol group in the study by Matsumoto et al. (12) was
recruited from patients undergoing coronary angiography
for angina symptoms. Some of these controls may have had
coronary endothelial dysfunction, which has been shown to
ps
ocalcin (OCN) than normal subjects, reaching statistical significance in all but
terquartile ranges are shown; diamonds represent mean values. Abbreviations as
rculating EPCs than normal subjects. *p  0.001,
diamonds represent mean values. Abbreviations as in Figure 1.Grou
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(10,13). In contrast, our controls have normal coronary
arteries and normal endothelial function (invasively as-
sessed) (10). Nevertheless, both studies implicate endothe-
lial injury with an impaired repair process in calcific AS.
The current study further elucidates the mechanism of
valvular calcification that may occur during the attempted
repair. Patients with sAS have not only have functionally
Figure 4 Colocalization of Inflammation
and Osteoblastic Activity
Immunofluorescence staining for nuclear factor kappa-B (NFkB) (red) and
osteocalcin (OCN) (green) of control (A, B) and severely calcified aortic valves
(C, D; blue represents DAPI stain). NFkB and OCN demonstrate colocalization
(yellow, examples indicated by white arrowheads), indicating that the osteo-
blastic process is associated with inflammation. Whereas calcified aortic
valves show NFkB/OCN costaining within the endothelial cell layer (C) and the
deeper valve tissue layers (D), control valves show costaining only within the
valve (B) and not within the endothelial cell layer (A). Magnification 40. For
individual color channels, please see Online Figures 1 and 2. AS  aortic
stenosis.
Analysis of Covariance Afterdjustment f r Confounding Risk factorsTable 2 An lysis of Covariance AfterAdjustment for Confounding Risk factors
Overall ANOVA p Values and Dunnett-Adjusted Pairwise Comparisons on
Transformed Data After Adjustment for Diabetes, Hypertension, and Smoking
Comparison
CD34 KDR OCN
(Log-Transform)
OCN of
CD34 KDR
(No Transform)
CD34 KDR OCN
(Log-Transform)
Overall (ANOVA) 0.001 0.001 0.001
Normal vs. mi-
moAS/no
CAD
0.13 0.001 0.001
Normal vs. sAS/
no CAD
0.029 0.23 0.66
Normal vs. sAS/
sCAD
0.84 0.26 0.012
ANOVA  analysis of variance; CAD  coronary artery disease; mi-moAS  mild to moderate
calcific aortic stenosis; sAS  severe calcific aortic stenosis; sCAD  severe coronary artery
disease.impaired EPCs but also a high number of circulating
EPC-OCN. Thus, rather than repair, engraftment of EPC-
OCN may lead to progressive calcification of the aortic
valve.
Further evidence for the active role of circulating osteo-
genic cells in valvular calcification comes from studies of
CD45/OCN cells in patients with end-stage aortic
valve disease and heterotopic ossification. Egan et al. (14)
showed that CD45/OCN cells represented 1.1% of
circulating mononuclear cells in their study population and
were localized to regions of heterotopic ossification.
The fact that we rarely found CD34/OCN cells in
ormal valves but an abundance of CD34/OCN cells in
he endothelial cell layer and the deeper valvular tissue of
everely calcified aortic valves further supports the concept
f attraction of osteogenic precursors to sites of valvular
njury and their active role in AVC.
Evidence of colocalization of inflammation (expression of
ctivated NFkB) and osteoblastic activity (OCN) within
eeper layers but not the endothelium of normal (noncal-
ified) valves in our study may suggest a role of resident
steogenic cells that are activated by an early inflammatory
rocess. One may speculate that resident osteogenic cells are
he first responders to early, modest valvular injury/
nflammation, and after more significant injury, particularly
o the valvular endothelial cell layer, circulating osteogenic
recursors are attracted, as suggested by the abundant
olocalization of inflammation and osteoblastic activity,
Figure 5 Immunofluorescence Staining
for Osteoblastic Progenitor Cells
Immunofluorescence staining for CD34 (red) and osteocalcin (OCN) (green) of
normal (A, B) and severely calcified aortic valves (C, D; blue represents DAPI
stain). CD34/OCN costaining (yellow, examples indicated by white arrow-
heads) is rarely observed within deeper valve tissue of control valves (B), but
not within the endothelial cell layer (A). In contrast, CD34/OCN cells are abun-
dant within the endothelial cell layer (C) and deeper valve tissue (D) of
severely calcified valves. Magnification 40. For individual color channels,
please see Online Figures 1 and 2. AS  aortic stenosis.
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valves.
Toutouzas et al. (15) demonstrated that aortic valve
inflammation is associated with neovascularization in pa-
tients with aortic valve stenosis. In the current study, we did
not assess aortic valve neovascularization; however, it is
conceivable that aortic valve neovascularization serves as an
entry port not only for inflammatory cells but also for
osteogenic circulating progenitor cells and, thus, promotes
valvular calcification.
Our current data are also supported by previous experi-
mental data in osteoprotegerin-deficient mice and a mouse
model of accelerated calcification through calcitriol admin-
istration. Pal et al. (16) found a strong correlation between
the amount of extracted aortic valve calcium and the
percentage of circulating OCN() EPCs. In addition, in a
subgroup of patients with peripheral artery disease, the same
authors found higher percentages of OCN() EPCs in
patients with higher AVC volume assessed by computed
tomography (16).
The mechanistic concept of blood-derived procalcific
cells is further supported by recent evidence of increased
numbers of circulating OCN/alkaline phosphatase my-
eloid cells in diabetic patients; Fadini et al. (17) demon-
strated that type 2 diabetic patients showed elevated num-
bers of these cells that were also adjacent to sites of
calcification in carotid endarterectomy specimens of diabetic
patients.
We analyzed a subgroup of our patients who were
younger and had severe calcific bicuspid aortic valves sched-
uled for aortic valve replacement. The comparison with
normal subjects of comparable age revealed a similar distri-
bution of EPCs and EPC-OCN seen between normal
subjects and patients with both sAS and sCAD. Thus, age
does not seem to be a major determinant for the decrease in
circulating EPCs, number of EPC-OCN, and percentage of
OCN costaining of circulating EPCs in the current study.
This is in line with our previous findings in which the
absolute number and percentage of EPC-OCN were age-
independent predictors of early and severe coronary athero-
sclerosis (10). Indeed, others have demonstrated that al-
though there is no significant difference in the number of
circulating EPCs between old individuals and young,
healthy individuals, EPCs from older individuals (61  2
ears) show functional impairments (lower survival, migra-
ion, and proliferation) (18). EPC senescence induced by
elomere shortening may contribute to these functional
mpairments in older individuals (19).
Not every patient with bicuspid aortic valve disease shows
arly, severe AVC. One may speculate that genetic factors
etermine the relative ratio of EPC-OCN and EPCs in an
ndividual and, thus, the onset and rate of progression of
ascular calcification. Prospective clinical studies will have to
how whether assessing EPC-OCN relative to EPCs in
atients with bicuspid aortic valve disease helps to prognos-
icate the rate of progression of bicuspid AVC and stenosis. tOur subgroup of patients with bicuspid aortic valves also
ay help to explain the restriction of the severe calcification
rocess to only 1 endothelial territory in some patients.
espite the fact that patients with severe bicuspid calcific
ortic valve stenosis show high percentages of OCN
ostaining and low numbers of circulating EPCs (similar to
ur sAS/sCAD group), only few show significant CAD. A
ombination of low total EPCs but high percentage of
PC-OCN may lead to early accelerated progression of
issue calcification in the most injured endothelial territory
e.g., a bicuspid valve exposed to high shear stresses). With
ging, this disadvantageous ratio of EPC-OCN/EPC likely
eads to multiterritory vascular calcification when more and
ore endothelial cell layers become significantly injured. In
atients with a more favorable ratio of EPC-OCN/EPC, a
etter functioning repair process may relatively delay the
alcification process. In such patients, severe, symptomatic
alcification may manifest later in life and only in the
ndothelial territory that showed aggressive endothelial
njury.
Clinical data show that 50% of patients with calcific AS
ave clinically significant CAD (20,21). Moreover, Otto et al.
22) showed that the risk of myocardial infarction is increased
n patients with calcific aortic valve disease, even in those
ithout clinically evident CAD. The current data may provide,
or the first time, a mechanistic explanation for this intriguing
ssociation. Patients with sAS and normal coronary arteries
howed high levels of circulating EPCs with an osteoblastic
otential, which may promote early initiation and progression
f coronary calcification. Coronary calcification, in turn, has
een shown to be associated with accelerated plaque progres-
ion (23) and higher event rates (24).
Figure 6 summarizes the potential mechanisms by which
irculating EPC-OCN may participate in AVC. As sum-
arized by Hermans et al. (25), all 3 typical layers of the
ortic valve are populated by valve interstitial cells (VICs)
hat maintain leaflet integrity. It is thought that in response
o injury, endothelial-mesenchymal transition gives rise to
uiescent VICs from embryonic progenitor endothelial/
esenchymal cells (26). These quiescent VICs likely maintain
alve integrity and inhibit neovascularization. Although acti-
ated VICs likely help the repair process, osteoblastic VICs
articipate in tissue calcification. A fourth type of VICs are
rogenitor VICs; however, their origin is unknown. One
ossible origin is the bone marrow via the circulation. On the
asis of our data, we hypothesize that circulating EPC-OCN
mplant into the endothelial cell layer and that the deeper cell
ayers of aortic valves may represent circulating progenitor
ICs. The fact that some patients have high percentages of
irculating EPC-OCN may predispose them to earlier and
ore significant activation of osteoblastic VICs on valve injury.
Alternatively, circulating EPC-OCN could represent
arkers of ongoing endothelial-mesenchymal transition, in
hich case they may be useful in the prognostication of
rogression of aortic and coronary valve calcification. Fur-
her experimental studies will have to elucidate whether
1952 Gössl et al. JACC Vol. 60, No. 19, 2012
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cation or are only markers of the disease.
Study limitations. Because our study focused on a dif-
ferent mechanism of calcific aortic valve stenosis, we did
not assess valvular endothelial cells or circulating EPCs
for senescence, migratory function, or apoptosis. In
addition, without using an experimental model, the
current study on human surgical specimens does not
allow exploring the definite mechanistic role of circulat-
ing EPC-OCN in the pathogenesis of AVC.
We used isotype controls instead of fluorescence-minus-
one controls in our 4-color flow-cytometry analyses. The
use of fluorescence-minus-one controls could have led to a
different gating strategy.
Our subgroup analysis of patients with bicuspid aortic
valve stenosis is limited to 12 patients, which is mainly
due to the low prevalence of the disease in the general
population and the fact that not all bicuspid valves calcify
to a surgical degree. The current study design does not
allow the assessment of prognosis of patients with calcific
aortic valve disease and certain levels of EPC-OCN.
Prospective long-term follow-up of our patients (espe-
cially those with mi-moAS) will demonstrate whether
those with higher numbers of EPC-OCN show acceler-
ated progression of calcific aortic valve stenosis.
Conclusions
We show for the first time that the percentage of EPC-
OCN in a given EPC population is significantly increased
in patients with varying degrees of AVC. Moreover, our
Figure 6 Possible Role of Circulating EPC-OCN in AVC
In the hypothesized interplay among the circulating EPC-OCN, the endothelial
cell layers of the aortic valve, and the VICs, EPC-OCN may engraft into the
endothelial cell layer or enter deeper valvular tissue layers and become VICs
(see “Discussion” for further details). AVC  aortic valve calcification; EC 
endothelial cell; EPC-OCN  circulating endothelial progenitor cells with osteo-
blastic phenotype; VIC  valve interstitial cell.data indicate that a combination of low total EPCs but highpercentage of EPC-OCN is independent of age and may
contribute to early and accelerated valvular and vascular
calcification.
Future prospective studies will show whether the number
of EPC-OCN relative to EPCs may be a marker of
prognostication for the onset and rate of progression of
valvular and coronary calcification and may be useful in
decision making about the aggressiveness of risk-factor
management of patients.
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